Case Reports in Medicine

Case Reports in Medicine / 2017 / Article

Case Report | Open Access

Volume 2017 |Article ID 6327437 | 5 pages | https://doi.org/10.1155/2017/6327437

Tongue Necrosis Secondary to Giant Cell Arteritis: A Case Report and Literature Review

Academic Editor: Bruno Megarbane
Received16 Nov 2016
Accepted14 Mar 2017
Published23 Mar 2017

Abstract

Giant cell arteritis is a form of vasculitis involving the medium- and large-sized arteries that chiefly affects older people. Clinical findings are headache, jaw claudication, fever, pain, and thickening of the temporal artery. The most feared complication is visual loss due to impairment of the ophthalmic artery and posterior ciliary arteries. This a case report of an 85-year-old male presenting with headache and jaw pain, who was admitted with tongue necrosis as an initial manifestation of giant cell arteritis. The necrotic area detached spontaneously after two weeks of therapy with corticosteroids and methotrexate. Reviewing the literature, our patient presented with clinical symptoms consistent with most reports, except for the fact of being male. Although unusual as an initial manifestation, tongue necrosis is an important alert for diagnosing giant cell arteritis. Early diagnosis and treatment of this atypical manifestation may reduce morbidity.

1. Introduction

Giant cell arteritis (GCA) is a form of vasculitis involving medium- and large-sized arteries, which mainly affects the extracranial branches of the internal and external carotid arteries, particularly the temporal artery. GCA occurs predominantly in females in a ratio of 1.4 to 3 women for every man and exclusively in patients aged 50 years and over [1, 2]. Common symptoms include headache; visual symptoms such as diplopia, amaurosis fugax, and vision loss; and masticatory muscle changes such as jaw claudication [3, 4].

Early diagnosis is vital in order to avoid complications, such as symptoms of ischemia [5, 6]. In some patients, however, unusual symptoms, such as lingual necrosis may appear as an initial manifestation, thus hindering diagnosis [79]. In this report, we present a case of GCA in an elderly male with early tongue necrosis.

2. Case Presentation

A male, aged 85 years, arrived in the emergency department having suffered from frontotemporal headache associated with jaw pain over a period of 30 days. He reported that the pain had worsened during the last seven days and that pain had also developed on the floor of the mouth and chin. He also presented with a medical history of hypertension, cataracts, and osteoporosis. On admission, neurological examination and neuroimaging indicated no significant changes.

On the second day of hospitalization, the patient presented with increased lingual volume associated with intense pain and difficulty in eating. Inspection of the tongue revealed diffuse edema, whitish plaques, and a small aphthous ulcer. Treatment was initiated for oral candidiasis with fluconazole, and later Candida dubliniensis was isolated from a lingual swab. Within 24 hours, the lesion had changed colour, becoming greyish in a bilateral well-defined area, suggesting an ischemic lesion (Figure 1). Temporal pulses were absent and transient bilateral amaurosis appeared, thus confirming the presumptive diagnosis of GCA. Prednisone therapy was initiated with 1 mg/kg/day.

Initial laboratory investigation indicated a complete blood count with mild leukocytosis, neutrophilia, thrombocytosis, and anemia (hemoglobin 11.7 g/dL, hematocrit 36%, 14,290 leukocytes/mm3 with 89% neutrophils, and 481,000 platelets/mm3). The erythrocyte sedimentation rate (ESR) of 120 mm/h and a C-reactive protein (CRP) of 17.2 mg/dl were consistent with an acute inflammatory process. Other laboratory tests were normal.

Doppler ultrasonography demonstrated that the temporal arteries were tortuous and presented diffuse intimal thickening with edema of the surrounding tissue (halo sign), and stenosis of around 75% of the light from the right temporal artery. A diagnosis of GCA was confirmed with a biopsy from the right temporal artery, which presented partial necrosis of the arterial wall with inflammatory infiltration mainly of mononuclear type (lymphocytes, histiocytes, plasma cells, and multinucleated giant cells) permeating the internal elastic lamina; calcification foci; and total lumen stenosis (Figure 2).

After glucocorticoid therapy was initiated, the patient presented a significant clinical and laboratory response. The area of ​​the tongue that displayed the delimited necrotic lesion detached spontaneously within fourteen days and there was no progression of the ischemic region (Figure 1). After two weeks was initiated methotrexate 10 mg/week, and the patient was discharged clinically stable, and during his outpatient visits no new events or recurrences of GCA were reported. The prednisone dose was initially reduced by 10 mg every month until 20 mg/day and then reduced slowly. After twelve months, with evidence of normal inflammatory activity, the glucocorticoid was completely withdrawn.

3. Discussion

The manifestations of GCA include headache in 90% of cases, polymyalgia rheumatica (34%), jaw claudication (50%), amaurosis fugax, and blurred vision (40%). Other findings include fever, increased erythrocyte sedimentation rate, leukocytosis, and abnormalities in the temporal artery [4, 6, 10]. Ocular symptoms should also be highlighted due to the risk of vision loss, for which treatment should be instituted promptly [2].

Lingual manifestations such as edema, pallor, pain, and intermittent claudication occur in up to 25% of cases and can be associated with a greater risk of ischemic complications. However, tongue necrosis is rare, given the rich blood supply to this tissue [1, 11]. GCA with tongue and/or scalp necrosis tends to occur more in older people and develops with more visual symptoms [7]. Tongue necrosis is an unfavorable prognostic sign since it is associated with increased mortality, although not part of the classification criteria [7].

While GCA is the main cause of tongue necrosis, other less common etiologies should be excluded, like carcinoma, embolism, drug use, radiation, syphilis, tuberculosis, chemotherapy, among others [1, 8, 12]. Other causes were not present in this case report; thus treatment was initiated for GCA, since the patient met four of the five criteria cited by the American College of Rheumatology: aged over 50 years, reduced temporal pulse, ESR greater than 50 mm/h, and a compatible biopsy [5, 8, 9].

The use of corticosteroids remains the cornerstone of therapy for GCA [3, 10]. The recommended dose is 1 mg/kg/day of prednisone for four to six weeks and, thereafter, tapering off begins aiming at a dose of 10 mg/day [5]. Recurrences occur in 50% of patients and adverse effects are common [13]. In cases involving visual loss or amaurosis fugax (complicated GCA) intravenous methylprednisolone is indicated for three days before oral glucocorticosteroids. It is possible to try to withdraw corticosteroids after four weeks, paying close attention to clinical symptoms and to ESR and CRP levels [14]. For adjunctive therapy, methotrexate, azathioprine, cyclophosphamide, and anti-TNF-alpha agents may be used [13]. Methotrexate is the first choice as steroid sparing drug because it has proven effective in reducing the cumulative dose of and preventing recurrences [13, 14].

The intensity of the initial inflammatory response of GCA can be determined by five parameters: Platelets > 400,000/mm3, temperature > 37.5°C, leukocytes > 11,000/mm3, ESR > 100 mm/h, and hemoglobin < 11 g/dl. Patients who meet four or five of these criteria are considered at high risk for recurrence and dependence on corticosteroids [15]. In this case, we chose to initiate methotrexate, given the severity of the recorded criteria (leukocytosis, thrombocytosis, and elevated ESR) associated with tongue necrosis, which in itself presents the worst prognosis. Moreover, the patient presented with comorbidities such as osteoporosis and cataracts, which indicate the need for early use of corticosteroid sparing.

A literature review was conducted using PubMed for case reports either in English or in Spanish of patients presenting with tongue necrosis as a clinical manifestation of GCA. We identified 22 articles published between 2000 and 2015 [112, 1625], which reported 25 cases (Table 1). We found that most patients with GCA-associated lingual necrosis were older females. The ratio was of twelve women for every man, with a mean age of 77 years and an ESR of 79 mm/h. By analyzing the pattern of necrosis, we observed that 80% of patients presented with local pain, 50% with tongue edema, and 28% progressed to ulceration. In relation to associated symptoms, only seven patients (29%) did not present with headache as an initial manifestation. Ocular symptoms, such as blurred vision and sudden visual loss, occurred in 38%. In this review, all patients were treated with high doses of corticosteroids and 28% received pulse therapy with methylprednisolone. The response to corticosteroids was, in the majority (76%) satisfactory, with good healing and disease control. Only one patient progressed to the need for a new course of methylprednisolone [11]. A second drug was used (intravenous cyclophosphamide, methotrexate, and azathioprine) in four cases [6, 11, 12, 25].


AuthorRef.Age/SexESRAssociated symptomsTreatment

Mumoli (2015)[16]77/FNoPain in the scapular cingulum, pain and swelling in both the wrists, transient reduction in visual acuity and headacheSteroids
Zaragoza (2015)[8]68/F55Moderate headache and swelling of the neckHigh dose corticosteroids at 1 mg/kg
Lobato-Berezo (2014)[17]74/FNoFatigue, anorexia, jaw pain and headache, with ptosis and blurred vision in her left eyePulse with methylprednisolone and oral prednisone 1 mg/kg/day
Kumar (2013)[18]74/M132High-grade fever, bilateral temporoparietal headache, jaw claudication and diminished vision in both eyesOral prednisolone 1 mg/kg/day
Grant (2013)[5]79/F68Sudden complete visual loss in the left eye and generalized ongoing headacheOral prednisolone 60 mg/day and pulse with 500 mg methylprednisolone for three days
Kumarasinghe (2012)[19]74/F103Vague history of mild headaches and jaw pain on chewingOral prednisolone 40 mg/day
Husein-ElAhmed (2012)[20]76/F87Generalised weaknessOral prednisone
Zadik (2011)[1]78/F69Pain of the right head, neck, face, and shoulder, fatigue, visual blurring and weight lossPrednisone 60 mg/day
Jennings (2011)[21]79/F75Fatigue, bilateral occipital neck pain and jaw claudicationSteroid treatment
Olivera (2010)[4]74/F83Headache, anorexia, weakness and jaw claudicationOral methylprednisolone 1 mg/kg
Brodmann (2009) Case  1[7]81/M52Chronic fatigueGlucocorticoid therapy
Brodmann (2009) Case  2[7]79/F70Sudden visual loss at the right eye, temporal headache and jaw claudicationHigh-dose steroid therapy
Zimmermann (2008)[22]81/F69Bitemporal headache, jaw claudication and mild limb-girdle symptomsHigh-dose intravenous hydrocortisone
Schurr (2008)[10]66/F120Slow speech and a worsening dysphagiaIntravenous prednisone 500 mg for 3 days, then reduced dose of 100 mg
Sainuddin (2008)[9]88/F78Generalized weaknessPrednisone 40 mg/day
Kusanale (2008)[23]86/F25No informationSteroids
Ciantar (2008)[12]74/F79Neck painMethylprednisolone 1 g IV for 3 days, prednisolone 60 mg/day and methotrexate 12.5 mg weekly
Goicochea (2007) Case  1[11]77/F40Asthenia, fever, right temporal headache, and hemifacial painMethylprednisolone 1 g IV, cyclophosphamide IV and prednisone 80 mg/day
Goicochea (2007) Case  2[11]73/F42Frontotemporal headache, arthralgias and lost vision in right eyeMethylprednisolone 1 g IV for 3 days and prednisone 80 mg/day
Goicochea (2007) Case  3[11]78/F125Headache, left eye visual loss, diplopia, fever and swellingMethylprednisolone 500 mg IV for 3 days and 60 mg/day orally
Lethert (2007)[24]77/F68Head, neck and jaw pain, fever, slurred speech and difficulty chewing.Corticosteroids
Biebl (2004)[6]79/F78Visual reduction on the left eye, abdominal pain with multiple segmental small bowel necrosisPrednisolone and azathioprine (100 mg/day each)
García (2003)[25]83/F67Fever, limb-girdle symptoms, occasional headacheCorticosteroids and methotrexate
Rockey (2002)[2]71/F125Headache, vasculitic rash in buttocks and ischemia over the distal phalanx of thumb and fifth metatarsals bilaterallyHigh-dose steroid therapy
Hellmann (2002)[3]79/F115Fatigue, cough, toothache and visual lossMethylprednisolone IV in high doses and prednisone 60 mg/day

Ref: reference; ESR: erythrocyte sedimentation rate; M: male; F: female.

For the above-mentioned reasons, our patient presented with clinical findings that were consistent with most reports, except for the fact of being male. Tongue necrosis should serve as a warning for GCA, although it is unusual as an initial manifestation. The physician should be aware of this atypical manifestation, especially since diagnosis and early treatment may change the natural course of the disease, thus reducing morbidity.

Conflicts of Interest

The authors declare that there are no conflicts of interest regarding the publication of this paper.

Acknowledgments

Authors thank the patient for sharing his story and Dr. Hely José Farias Neto (in memoriam) for initial patient care.

References

  1. Y. Zadik, M. Findler, A. Maly, H. Rushinek, and R. Czerninski, “A 78-year-old woman with bilateral tongue necrosis,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 111, no. 1, pp. 15–19, 2011. View at: Publisher Site | Google Scholar
  2. J. G. Rockey and R. Anand, “Tongue necrosis secondary to temporal arteritis: a case report and literature review,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol. 94, no. 4, pp. 471–473, 2002. View at: Publisher Site | Google Scholar
  3. D. B. Hellmann, “Temporal arteritis: a cough, toothache, and tongue infarction,” Journal of the American Medical Association, vol. 287, no. 22, pp. 2996–3000, 2002. View at: Publisher Site | Google Scholar
  4. S. Olivera, B. Amores, M. Torralba, and J. Pérez Calvo, “Paciente con complicación poco frecuente de arteritis de células gigantes,” Anales del Sistema Sanitario de Navarra, vol. 33, no. 3, pp. 327–330, 2010. View at: Publisher Site | Google Scholar
  5. S. W. J. Grant, H. C. Underhill, and P. Atkin, “Giant cell arteritis affecting the tongue: a case report and review of the literature,” Dental Update, vol. 40, no. 8, pp. 669–677, 2013. View at: Google Scholar
  6. M. O. Biebl, B. Hugl, L. Posch et al., “Subtotal tongue necrosis in delayed diagnosed giant-cell arteritis: a case report,” American Journal of Otolaryngology—Head and Neck Medicine and Surgery, vol. 25, no. 6, pp. 438–441, 2004. View at: Publisher Site | Google Scholar
  7. M. Brodmann, A. Dorr, F. Hafner, T. Gary, and E. Pilger, “Tongue necrosis as first symptom of giant cell arteritis (GCA),” Clinical Rheumatology, vol. 28, no. 1, pp. S47–S49, 2009. View at: Publisher Site | Google Scholar
  8. J. R. Zaragoza, N. Vernon, and G. Ghaffari, “Tongue necrosis as an initial manifestation of giant cell arteritis: case report and review of the literature,” Case Reports in Rheumatology, vol. 2015, Article ID 901795, 4 pages, 2015. View at: Publisher Site | Google Scholar
  9. S. Sainuddin and N. R. Saeed, “Acute bilateral tongue necrosis—a case report,” British Journal of Oral and Maxillofacial Surgery, vol. 46, no. 8, pp. 671–672, 2008. View at: Publisher Site | Google Scholar
  10. C. Schurr, A. Berthele, M. Burghartz, and J. Kiefer, “Spontaneous bilateral necrosis of the tongue: a manifestation of giant cell arteritis?” European Archives of Oto-Rhino-Laryngology, vol. 265, no. 8, pp. 993–998, 2008. View at: Publisher Site | Google Scholar
  11. M. Goicochea, J. Correale, L. Bonamico et al., “Tongue necrosis in temporal arteritis,” Headache, vol. 47, no. 8, pp. 1213–1215, 2007. View at: Publisher Site | Google Scholar
  12. M. Ciantar and D. M. Adlam, “Glossodynia and necrosis of the tongue caused by giant cell arteritis,” British Journal of Oral and Maxillofacial Surgery, vol. 46, no. 3, pp. 231–233, 2008. View at: Publisher Site | Google Scholar
  13. J. Choulerton and R. Luqmani, “Management of corticosteroid resistant giant cell arteritis,” Acta Reumatológica Portuguesa, vol. 30, pp. 329–339, 2005. View at: Google Scholar
  14. B. Dasgupta, F. A. Borg, N. Hassan et al., “BSR and BHPR guidelines for the management of giant cell arteritis,” Rheumatology, vol. 49, no. 8, pp. 1594–1597, 2010. View at: Publisher Site | Google Scholar
  15. G. Nesher, R. Nesher, M. Mates, M. Sonnenblick, and G. S. Breuer, “Giant cell arteritis: intensity of the initial systemic inflammatory response and the course of the disease,” Clinical and Experimental Rheumatology, vol. 26, no. 3, pp. S30–S34, 2008. View at: Google Scholar
  16. N. Mumoli, M. Cei, J. Vitale, and F. Dentali, “Tongue necrosis in giant-cell arteritis,” QJM, vol. 108, no. 10, article 841, 2015. View at: Publisher Site | Google Scholar
  17. A. Lobato-Berezo, M. Alcalde-Villar, A. Imbernõn-Moya, M. Martínez-Pérez, A. Aguilar-Martínez, and P. Collado-Ramos, “Tongue necrosis: an unusual clinical presentation of giant cell arteritis,” Arthritis and Rheumatology, vol. 66, no. 10, article 2803, 2014. View at: Publisher Site | Google Scholar
  18. R. Kumar, H. Gupta, A. Jadhav, and S. V. Khadilkar, “Bitemporal scalp, lip and tongue necrosis in giant cell arteritis: a rare presentation,” Indian Journal of Dermatology, vol. 58, no. 4, p. 328, 2013. View at: Publisher Site | Google Scholar
  19. A. P. Kumarasinghe, A. Hepburn, W. J. Reuther, and C. Pratt, “Temporal arteritis presenting with tongue necrosis,” BMJ Case Reports, vol. 2012, 2012. View at: Google Scholar
  20. H. Husein-ElAhmed, J.-L. Callejas-Rubio, R. Rios-Fernández, and N. Ortego-Centeno, “Tongue infarction as first symptom of temporal arteritis,” Rheumatology International, vol. 32, no. 3, pp. 799–800, 2012. View at: Publisher Site | Google Scholar
  21. S. Jennings and S. Singh, “Necrotic tongue: a rare manifestation of giant cell arteritis,” Journal of Rheumatology, vol. 38, no. 12, article 2688, 2011. View at: Publisher Site | Google Scholar
  22. A. T. Zimmermann and M. Brown, “Tongue infarction in giant cell (temporal) arteritis,” Internal Medicine Journal, vol. 38, no. 5, p. 376, 2008. View at: Publisher Site | Google Scholar
  23. A. Kusanale, H. Boardman, and H. Khoshnaw, “Tongue necrosis: a rare presentation of temporal arteritis,” Age and Ageing, vol. 37, no. 1, article 119, 2008. View at: Publisher Site | Google Scholar
  24. K. H. Lethert and D. F. Jacobson, “Tongue necrosis from temporal arteritis,” Journal of Hospital Medicine, vol. 2, no. 5, article 335, 2007. View at: Publisher Site | Google Scholar
  25. E. M. García, I. P. Tomás, E. O. Pastor, and A. J. F. Pérez, “Necrosis lingual como inicio de la arteritis temporal,” Acta Otorrinolaringológica Española, vol. 54, no. 1, pp. 74–77, 2003. View at: Google Scholar

Copyright © 2017 Rafael Alex Barbosa de Siqueira Sobrinho et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

1557 Views | 347 Downloads | 4 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.